X-Message-Number: 8145
From: John de Rivaz <>
Newsgroups: sci.cryonics
Subject: Re: BioTime advances
Date: Sun, 27 Apr 1997 10:59:40 +0100
Message-ID: <>

References: <> 
<>

As I understand it - others may correct me - Biotime is a company engaged in 
research aimed at the medical establishment, but it does have cryonicsts as 
investors and the substantial growth in the share price has benefited the 
cryonics organisation(s) that are investors. I do not have the exact figures 
to hand, but I think the stock quotation has risen by a factor of about 
fifteen times over the last couple of years. This may be due to the fact that 
the stock is tighly held, and lightly traded ie there are few sellers. There 
probably was a seller recently when there was a dip in the price, but the 
announcement I copied to this NG was accompanied by a sharp recovery. Anyone 
dealing in the stock will probably affect the price as stock jobbers will 
mark it up (if bought) or down (if sold) when business is offered, before 
making the deal.


This is the price at the end of Friday

                                                             DAYS    (00s)
    SYMBL  SECURITY                            CLOSE         CHANGE   VOL
   ----------------------------------------------------------------------
April
21 BTIM   Biotime............................   28 1/2     -1 3/4     400
22 BTIM   Biotime............................   25 3/4     -2 3/4    1146
23 BTIM   Biotime............................   25 3/8     -  3/8     785
24 BTIM   Biotime............................   27 1/2     +2 1/8    1599
25 BTIM   Biotime............................   31         +3 1/2    5288

Small Bio stocks are not like electronics stocks, they can rise sharply on 
good news and then fall sharply as financiers realise that regulatory delays 
will mean five or more years wait until the products appear on pharmacy 
shelves and profits in the accounts. However they can be bought after the 
subsequent fall to benefit from the eventual rise in profits, or a possible 
takover by a major company wanting the patents. 

The larger companies, such as Warner Lambert, have so many products that the 
rise is steady and indeed some commentators have said that they are taking on 
the characteristics of go-go electronics stocks. New technology has vastly 
increased the throughput of exploratory research by factors of thousands to 
one. The regulatory delay means that this pharmaceuticals boom will not be 
seen on balance sheets until a few years into the next decade, but in the 
meantime it is a good prop against bad news on current activities.


In article: <>   
(Randy) writes:
> 
> 
> On Sat, 26 Apr 1997 09:54:41 +0100, John de Rivaz
> <> wrote:
> 
> >	Biotime and Abbott  in licensing pact
> >
> snipped....
> 
> John, are these guys doing actual cryonics research. or just
> cryobiology research?
> Randy   
> Cryonics: Gateway to the Future?
> http://members.wbs.net/homepages/c/r/y/cryofan1.html             
> ***********************************
> 
> 
-- 
               *****************************************
Sincerely,     *          Longevity Report             *
               * http://www.longevb.demon.co.uk/lr.htm *
John de Rivaz  *           Fractal Report              *
               * http://www.longevb.demon.co.uk/fr.htm *
               *       Music I like - see homepage     *
               *****************************************
    In the information age, sharing can increase world
    wealth enormously, because giving information does
              not decrease your information.
     http://ourworld.compuserve.com/homepages/JohndeR                        
      Fast loading, very few slow pictures

Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=8145